Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 157
Filter
2.
Clin Exp Dermatol ; 45(2): 207-211, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31361915

ABSTRACT

We describe two patients with BRAF-mutated melanoma of the epithelioid cell type arising from primary acquired melanosis with severe atypia of the right bulbar conjunctiva. Patient 1 was a 71-year-old Japanese man. After adjuvant cryotherapy and enucleation of the right eyeball, therapy with vemurafenib was administered for a distant metastasis to a lumbar vertebra, accompanied by erythema multiforme and two keratinous tumours. The patient died due to metastases to the liver and multiple vertebrae, despite therapy with nivolumab and combination therapy with dabrafenib plus trametinib. Patient 2 was a 72-year-old Japanese man. After adjuvant cryotherapy, periodic mitomycin C eye drops, and excision of the superficial portion of the right parotid gland and the dissection of cervical lymph nodes, he was treated with adjuvant combination therapy with dabrafenib plus trametinib. Dermatologists should be familiar with BRAF-mutated conjunctival melanoma, which is usually located on the bulbar conjunctiva and associated with more frequent distant metastasis.


Subject(s)
Conjunctival Neoplasms/genetics , Melanoma/genetics , Mutation , Proto-Oncogene Proteins B-raf/genetics , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Conjunctiva/pathology , Conjunctiva/surgery , Conjunctival Neoplasms/pathology , Conjunctival Neoplasms/therapy , Fatal Outcome , Humans , Liver Neoplasms/secondary , Lymphatic Metastasis , MAP Kinase Kinase Kinases/antagonists & inhibitors , Male , Melanoma/pathology , Melanoma/secondary , Melanoma/therapy , Protein Kinase Inhibitors/therapeutic use , Proto-Oncogene Proteins B-raf/antagonists & inhibitors
6.
Br J Dermatol ; 177(6): 1732-1736, 2017 12.
Article in English | MEDLINE | ID: mdl-28369922

ABSTRACT

Patients with deficiency of interleukin-36 receptor antagonist (DITRA), due to mutation of IL36RN, exhibit psoriatic phenotypes, typically generalized pustular psoriasis (GPP). We report a paediatric patient with DITRA, whose cutaneous lesions varied from psoriasis vulgaris in infancy to annular pustular psoriasis with acute exacerbation to GPP at 13 years of age. Conventional systemic treatments for GPP, which include oral retinoids, ciclosporin and methotrexate, are controversial in paediatric cases, because of their adverse effects and uncertain long-term consequences. Granulocyte monocyte apheresis, a process associated with few adverse events, promptly controlled the GPP of our paediatric patient, and has potential as a suitable alternative treatment for paediatric patients with DITRA.


Subject(s)
Cytapheresis/methods , Granulocytes , Interleukins/genetics , Monocytes , Psoriasis/therapy , Adolescent , Humans , Male , Mutation/genetics , Psoriasis/genetics , Treatment Outcome
7.
Vox Sang ; 96(1): 14-9, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19121193

ABSTRACT

BACKGROUND AND OBJECTIVES: Hepatitis A virus (HAV) transmission via contaminated blood products has been reported. Cell-adapted HAV strains are generally used to confirm virus inactivation in manufacturing blood products, but the strains may differ in their sensitivity to inactivation treatment. To select an appropriate cell-adapted HAV strain for virus validation, we compared the inactivation efficiency among four strains under two different physical inactivation treatments: heat and high hydrostatic pressure. MATERIALS AND METHODS: The cell-adapted HAV strains used here were KRM238, KRM003 (subgenotype IIIB), KRM031 (IA), and TKM005 (IB). The strains were treated at 60 degrees C for up to 10 h or under high hydrostatic pressure (up to 420 MPa). The reduction in HAV infectivity was measured by an immunofocus-staining method. RESULTS: The heat treatment at 60 degrees C for 10 h reduced HAV infectivity in the range of 3 to 5 log(10) among the strains; KRM238 and TKM005 were harder to inactivate than the other two. The high hydrostatic pressure treatment at 420 MPa also reduced infectivity in the range of 3 to 5 log(10) among the strains, and KRM031 was easier to inactivate than the other strains. CONCLUSION: Heat treatment and high hydrostatic pressure treatment revealed differences in inactivation efficiencies among cell-adapted HAV strains, and each strain reacted differently depending on the treatment. KRM238 may be the best candidate for virus validation to ensure the safety of blood products against viral contamination, as it is harder to inactivate and it replicates better in cell culture than the other strains.


Subject(s)
Blood Safety/methods , Hepatitis A virus/physiology , Hot Temperature , Hydrostatic Pressure , Virus Inactivation , Animals , Cell Line , Chlorocebus aethiops , Hepatitis A virus/classification , Hepatitis A virus/growth & development , Kidney , Species Specificity , Virus Cultivation
8.
Gut ; 57(10): 1431-40, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18579666

ABSTRACT

BACKGROUND: Obesity is a risk factor for acute pancreatitis (AP), but the molecular mechanism remains unclear. Adiponectin, an adipose tissue-derived secretory factor, has anti-inflammatory properties in addition to various biological functions, and its plasma concentrations are reduced in obese subjects. However, the role of adiponectin in AP has not been investigated. AIM: To determine the effects of adiponectin on AP. METHODS: We investigated the effects of adiponectin on experimental AP by using adiponectin-knockout (APN-KO) mice and adenovirus-mediated adiponectin over-expression. AP was induced by 10 hourly intraperitoneal injections of low-dose caerulein (10 microg/kg) after 2 week feeding of normal chow or a high-fat diet (HFD) in wild-type (WT) and APN-KO mice. We evaluated the severity of AP biochemically and morphologically. RESULTS: Low-dose caerulein treatment did not induce pancreatic damage in either WT or APN-KO mice under normal chow feeding. APN-KO mice, but not WT mice, fed a HFD and then treated with caerulein developed pancreatic damage and inflammation, accompanied by increased macrophage/neutrophil infiltration and upregulation of pro-inflammatory mediators such as tumour necrosis factor alpha in the pancreas. Adenovirus-mediated over-expression of adiponectin attenuated the severity of HFD/caerulein-induced AP in APN-KO mice. CONCLUSIONS: Adiponectin plays a protective role in caerulein-induced AP in HFD-fed mice.


Subject(s)
Adiponectin/physiology , Pancreatitis/prevention & control , Acute Disease , Adiponectin/metabolism , Adipose Tissue/metabolism , Adipose Tissue/pathology , Animals , Ceruletide , Dietary Fats/administration & dosage , Humans , Mice , Mice, Inbred C57BL , Mice, Knockout , Obesity/complications , Pancreatitis/chemically induced , Pancreatitis/metabolism , Pancreatitis/pathology , Reverse Transcriptase Polymerase Chain Reaction , Up-Regulation
10.
Gut ; 54(6): 789-96, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15888786

ABSTRACT

BACKGROUND AND AIMS: A characteristic feature of Crohn's disease (CD) is mesenteric adipose tissue hypertrophy. Mesenteric adipocytes or specific proteins secreted by them may play a role in the pathogenesis of CD. We recently identified adiponectin as an adipocyte specific protein with anti-inflammatory properties. Here we report on expression of adiponectin in mesenteric adipose tissue of CD patients. METHODS AND RESULTS: Mesenteric adipose tissue specimens were obtained from patients with CD (n = 22), ulcerative colitis (UC) (n = 8) and, for controls, colon carcinoma patients (n = 28) who underwent intestinal resection. Adiponectin concentrations were determined by enzyme linked immunosorbent assay, and adiponectin mRNA levels were determined by real time quantitative reverse transcription-polymerase chain reaction. Tissue concentrations and release of adiponectin were significantly increased in hypertrophied mesenteric adipose tissue of CD patients compared with normal mesenteric adipose tissue of CD patients (p = 0.002, p = 0.040, respectively), UC patients (p = 0.002, p = 0.003), and controls (p<0.0001, p<0.0001). Adiponectin mRNA levels were significantly higher in hypertrophied mesenteric adipose tissue of CD patients than in paired normal mesenteric adipose tissue from the same subjects (p = 0.024). Adiponectin concentrations in hypertrophied mesenteric adipose tissue of CD patients with an internal fistula were significantly lower than those of CD patients without an internal fistula (p = 0.003). CONCLUSIONS: Our results suggest that adipocytes in hypertrophied mesenteric adipose tissue produce and secrete significant amounts of adiponectin, which could be involved in the regulation of intestinal inflammation associated with CD.


Subject(s)
Adipose Tissue/metabolism , Crohn Disease/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Mesentery/metabolism , Adipocytes/metabolism , Adipocytes/pathology , Adiponectin , Adipose Tissue/pathology , Adult , Body Mass Index , Case-Control Studies , Crohn Disease/pathology , Female , Humans , Hypertrophy , Interleukin-6/metabolism , Male , Mesentery/pathology , Middle Aged , RNA, Messenger/metabolism
12.
Gut ; 52(6): 813-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12740336

ABSTRACT

BACKGROUND: We previously reported that gastrin induces expression of CXC chemokines through activation of nuclear factor kappaB (NFkappaB) in gastric epithelial cells that express gastrin receptor. AIMS: To clarify gastrin receptor mediated signals leading to activation of NFkappaB. METHODS: MKGR26 cells were created by transfecting gastrin receptor cDNA into MKN-28 cells. Degradation of inhibitor kappaB (IkappaB) and phosphorylation of protein kinase C (PKC)-delta were both detected by western blot analysis. NFkappaB activation was determined by luciferase assay and electrophoretic mobility shift analysis. RESULTS: Gastrin induced degradation of IkappaB-alpha and activation of NFkappaB, which was abolished by the selective gastrin receptor antagonist L-740,093 and the general PKC inhibitor GF109203X. Gastrin induced phosphorylation of PKC-delta, and its inhibitor rottlerin partially suppressed NFkappaB activation. However, the mitogen activated protein kinase (MAPK) kinase inhibitor PD98059, p38 MAPK inhibitor SB203580, and tyrphostin AG1478 had no effect on NFkappaB activation. Introduction of the dominant negative mutant of IkappaB kinase, of NFkappaB inducing kinase, and of tumour necrosis factor receptor associated factor 6 (TRAF6), but not that of TRAF2, inhibited gastrin induced activation of NFkappaB. CONCLUSIONS: Gastrin activates NFkappaB via a PKC dependent pathway which involves IkappaB kinase, NFkappaB inducing kinase, and TRAF6.


Subject(s)
Gastric Mucosa/drug effects , Gastrins/pharmacology , NF-kappa B/metabolism , Protein Kinase C/physiology , Proteins/physiology , Animals , Blotting, Western , Cell Line , DNA, Complementary/genetics , Gastric Mucosa/cytology , Gastric Mucosa/metabolism , Guinea Pigs , Humans , NF-kappa B/antagonists & inhibitors , Phosphorylation , Protein Kinase C/antagonists & inhibitors , Protein Serine-Threonine Kinases/physiology , Receptors, Cholecystokinin/antagonists & inhibitors , Receptors, Cholecystokinin/genetics , Receptors, Cholecystokinin/physiology , Signal Transduction/drug effects , TNF Receptor-Associated Factor 6 , Transfection , Tumor Cells, Cultured , NF-kappaB-Inducing Kinase
13.
Inflamm Res ; 51(8): 409-15, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12234058

ABSTRACT

OBJECTIVE: To elucidate the role of macrophages in the pathogenesis of inflammatory bowel disease, proinflammatory characteristics of macrophages were estimated in a murine model of spontaneous intestinal inflammation. MATERIALS AND METHODS: Peritoneal macrophages from IL-10deficient mice were stimulated with lipopolysaccharide (LPS) or an anti-CD40 monoclonal antibody (mAb). Cytokine release was assessed by enzyme-linked immunosorbent assay. CD40 expression was examined by two-color flow cytometric analysis. Induction of suppressor of cytokine signaling 3 (SOCS3) mRNA was evaluated by real-time quantitative RT-PCR. RESULTS: In the presence of LPS or anti-CD40 mAb, TNF-alpha and IL-12p70 release from macrophages of mutant mice was significantly higher than that from macrophages of wild-type mice. This may be due to the difference in IL-10 production by macrophages, since activated macrophages of wild-type mice produced IL-10 in amounts sufficient to suppress an increased release of cytokines from activated macrophages of mutant mice. LPS and CD40 stimulation induced significantly high level of SOCS3 expression in macrophages of mutant mice in comparison to those of wild-type mice. CONCLUSIONS: Macrophages from a murine model of inflammatory bowel disease demonstrated enhanced responsiveness to immunological and bacterial stimuli. This suggests significant roles of macrophages in the pathogenesis of inflammatory bowel disease.


Subject(s)
CD40 Antigens/immunology , Disease Models, Animal , Inflammatory Bowel Diseases/immunology , Inflammatory Bowel Diseases/pathology , Interleukin-10/deficiency , Lipopolysaccharides/immunology , Macrophages, Peritoneal/immunology , Repressor Proteins , Transcription Factors , Animals , CD40 Antigens/metabolism , Cytokines/biosynthesis , Gene Expression Regulation , Inflammation/immunology , Interleukin-10/biosynthesis , Interleukin-10/genetics , Interleukin-10/metabolism , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins
14.
Neuroscience ; 111(1): 151-62, 2002.
Article in English | MEDLINE | ID: mdl-11955719

ABSTRACT

The hypothalamo-neurohypophysial system, containing arginine vasopressin and oxytocin, is well known to show reversible morphological reorganization for both neurons and glial cells during chronic physiological stimulation. To determine the molecular background for these morphological changes, we investigated the expression of tubulin and microtubule-associated protein (MAP) 2d in the neurohypophysial astrocytes, pituicytes of adult rats by using reverse transcription-polymerase chain reaction, western blot, and immunohistochemistry. The mRNA of MAP2d was expressed at higher levels than that of MAP2c in the neurohypophysis, cerebral cortex, and cerebellum. In contrast, predominant expression of mRNA of MAP2c was detected in the olfactory bulb. Western blot analysis showed the presence of MAP2d in the neurohypophysis, however the amount was below the detection level in the cerebral cortex and cerebellum. A double labeling study using a confocal laser scanning microscope showed intense tubulin immunoreactivity in the glial fibrillary acidic protein (GFAP)-positive pituicytes of the intact neurohypophysis. Almost no tubulin immunoreactivity was observed in the astrocytes of the intact cerebral cortex, cerebellum, and supraoptic nucleus, in contrast to strong tubulin immunoreactivity in neuronal dendrites and somata. Interestingly, intense tubulin immunoreactivity was also observed in the GFAP-positive reactive astrocytes in the immediate vicinity of the artificial lesion of the cerebral cortex. Electron microscopic observation further demonstrated the presence of a lot of microtubules in the pituicytes of intact rats.The present results demonstrate that pituicytes in the adult rat neurohypophysis expresses high levels of tubulin and MAP2d compared with normal brain astrocytes, and suggest that the ability of astrocytic morphological alteration may be at least partly ascribed to this high expression of microtubule proteins.


Subject(s)
Astrocytes/metabolism , Microtubule-Associated Proteins/metabolism , Pituitary Gland, Posterior/metabolism , Tubulin/metabolism , Animals , Astrocytes/ultrastructure , Blotting, Western , Immunohistochemistry , Male , Microscopy, Confocal , Microscopy, Electron , Microtubule-Associated Proteins/genetics , Microtubules/ultrastructure , Molecular Weight , Pituitary Gland, Posterior/cytology , Pituitary Gland, Posterior/ultrastructure , RNA, Messenger/metabolism , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Tissue Distribution
15.
Int J Cancer ; 94(3): 335-42, 2001 Nov 01.
Article in English | MEDLINE | ID: mdl-11745411

ABSTRACT

Peroxisome proliferator-activated receptor gamma (PPARgamma) inhibits the growth of several types of cancer cells. However, the mechanisms by which this occurs are poorly understood. The goal of the present study was to investigate the effects of PPARgamma on mutated ras-induced cell growth, activation of transcription factors and expression of genes associated with cellular transformation in rat intestinal epithelial cells. A human PPARgamma cDNA was introduced to the activated H-ras-transfected IEC-6 cells (IECras) and 1 clone (IECrasPR82) that stably expresses both activated ras and PPARgamma was obtained. Thiazolidinedione derivatives such as troglitazone and rosiglitazone, selective ligands for PPARgamma, inhibited the cellular growth of IECrasPR82 cells in a time-dependent manner and induced G1 cell cycle arrest. Treatment with troglitazone (20 microM) decreased the expression of cyclin D1, heparin-binding epidermal growth factor-like growth factor (HB-EGF) and amphiregulin and suppressed the promoter activities of cyclin D1 and HB-EGF. Furthermore, a luciferase assay and an electrophoretic mobility shift assay showed that thiazolidinedione derivatives suppressed the transcriptional activities of AP-1 and Ets, both of which play crucial roles in the expression of cyclin D1 and HB-EGF. These findings suggest that reduction of EGF-like growth factors and cyclin D1 through the suppression of AP-1 and Ets may be 1 mechanism whereby PPARgamma inhibits their growth.


Subject(s)
Cyclin D1/biosynthesis , Epidermal Growth Factor/biosynthesis , Receptors, Cytoplasmic and Nuclear/agonists , Thiazolidinediones , Transcription Factors/agonists , ras Proteins/metabolism , Animals , Blotting, Northern , Blotting, Western , Cell Division/drug effects , Cell Line , Cell Line, Transformed , Cell Nucleus/metabolism , Chromans/pharmacology , Cyclin D1/antagonists & inhibitors , Cyclin D1/metabolism , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Epidermal Growth Factor/antagonists & inhibitors , Epithelial Cells/metabolism , Flow Cytometry , Humans , Hypoglycemic Agents/pharmacology , Intestines/cytology , Ligands , Luciferases/metabolism , Plasmids/metabolism , Promoter Regions, Genetic , RNA, Messenger/metabolism , Rats , Rosiglitazone , Thiazoles/pharmacology , Time Factors , Transcription Factor AP-1/metabolism , Transcription, Genetic , Transcriptional Activation , Transfection , Troglitazone
16.
Neurosci Lett ; 310(2-3): 141-4, 2001 Sep 14.
Article in English | MEDLINE | ID: mdl-11585587

ABSTRACT

Inhibitors of cytochrome P-450 augment fever in rats and mice, indicating that the metabolite of the enzyme is candidate of endogenous antipyretic. Cytochrome P-450 of arachidonic acid cascade leads to the formation of regioisomeric 5,6-, 8,9- 11,12- and 14,15-epoxyeicosatrienoic acid (EET). Various isomers of EET were administrated into the preoptic area and anterior hypothalamus (PO/AH) to test their influence on fever induced by interleukin-1beta (IL-1beta) administrated into the PO/AH in conscious rats. The IL-beta-induced fever was attenuated in the 11,12-EET-pretreated rats, although 5,6-, 8,9- and 14,15-EET did not affect the fever. Intra-PO/AH injection of 11,12-EET did not alter normal body temperature. The results suggest that 11,12-EET acts in the hypothalamus as an endogenous antipyretic.


Subject(s)
8,11,14-Eicosatrienoic Acid/analogs & derivatives , 8,11,14-Eicosatrienoic Acid/metabolism , Anterior Hypothalamic Nucleus/metabolism , Fever/metabolism , Preoptic Area/metabolism , Vasodilator Agents/pharmacology , Analgesics, Non-Narcotic/pharmacology , Animals , Anterior Hypothalamic Nucleus/drug effects , Arachidonic Acid/metabolism , Cytochrome P-450 Enzyme System/metabolism , Fever/chemically induced , Interleukin-1/pharmacology , Male , Preoptic Area/drug effects , Rats , Rats, Wistar
17.
Nephrol Dial Transplant ; 16(10): 2067-71, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11572898

ABSTRACT

BACKGROUND: Various clinical and biochemical parameters are currently in use for monitoring allograft rejection. However, the mechanism of allograft rejection is complex and it is frequently difficult to obtain a prompt and accurate diagnosis. We examined the usefulness of OK432-induced killer cell activity as an immunological monitoring system for acute renal rejection after renal transplantation. METHODS: Twenty-four renal transplant recipients, seven patients on haemodialysis, and 10 normal volunteers were enrolled in our study. The killer cell activity of peripheral blood mononuclear cells was induced by culturing these cells with the immunopotentiator, OK432, a heat and penicillin-treated lyophilized powder of the Su-strain of Streptococcus pyogenes. RESULTS: The OK432-induced killer cell activity of renal transplant recipients without acute rejection (stable recipients) was significantly lower than in normal volunteers. In four renal transplant recipients with acute rejection, the killer cell activity was significantly higher than in stable recipients. In three recipients suffering from opportunistic infections, killer cell activity was significantly suppressed compared with stable recipients. CONCLUSIONS: Our new test utilizing OK432-induced killer cell activity is potentially useful for monitoring the immunological state and complications after renal transplantation.


Subject(s)
Adjuvants, Immunologic/pharmacology , Kidney Transplantation/adverse effects , Kidney Transplantation/immunology , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Picibanil/pharmacology , Adolescent , Adult , Female , Graft Rejection/immunology , Humans , Immunosuppressive Agents/pharmacology , In Vitro Techniques , Male , Middle Aged , Opportunistic Infections/immunology
18.
Cell Biochem Funct ; 19(3): 213-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11494311

ABSTRACT

The role of intracellular Ca2+ stores and capacitative Ca2+ entry on EGF-induced cell proliferation was investigated in mouse mammary epithelial cells. We have previously demonstrated that EGF enhances Ca2+ mobilization (release of Ca2+ from intracellular Ca2+ stores) and capacitative Ca2+ entry correlated with cell proliferation in mouse mammary epithelial cells. To confirm their role on EGF-induced cell cycle progression, we studied the effects of 2,5-di-tert-butylhydroquinone (DBHQ), a reversible inhibitor of the Ca2+ pump of intracellular Ca2+ stores, and SK&F 96365, a blocker of capacitative Ca2+ entry, on mitotic activity induced by EGF. Mitotic activity was examined using an antibody to PCNA for immunocytochemistry. SK&F 96365 inhibited capacitative Ca2+ entry in a dose-dependent manner (I50: 1-5 microM). SK&F 96365 also inhibited EGF-induced cell proliferation in the same range of concentration (I50: 1-5 microM). DBHQ suppressed [Ca2+]i response to UTP and thus depleted completely Ca2+ stores at 5 microM. DBHQ also inhibited EGF-induced cell proliferation at an I50 value of approximately 10 microM. The removal of these inhibitors from the culture medium increased the reduced mitotic activity reversibly. Using a fluorescent assay of DNA binding of ethidium bromide, no dead cells were detected in any of the cultures. These results indicate that the inhibitory effects of SK&F 96365 and DBHQ on cell proliferation were due to the inhibition of capacitative Ca2+ entry and Ca2+ mobilization suggesting the importance of capacitative Ca2+ entry and Ca2+ mobilization in the control of EGF-induced cell cycle progression in mouse mammary epithelial cells.


Subject(s)
Calcium/metabolism , Epidermal Growth Factor/pharmacology , Epithelial Cells/metabolism , Hydroquinones/pharmacology , Imidazoles/pharmacology , Mammary Glands, Animal/metabolism , Adenosine Triphosphate/metabolism , Animals , Calcium/antagonists & inhibitors , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Calcium-Transporting ATPases/antagonists & inhibitors , Cell Division/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Epithelial Cells/drug effects , Female , Immunohistochemistry , Mice , Mice, Inbred ICR , Pregnancy , Proliferating Cell Nuclear Antigen/metabolism , Uridine Triphosphate/metabolism
19.
Jpn J Physiol ; 51(3): 389-93, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11492965

ABSTRACT

Reactive Blue 2 (RB), which is used as an ATP receptor antagonist, induced Ca(2+) oscillations in HeLa cells. RB-induced Ca(2+) oscillations were abolished in Ca(2+)-free solution. RB, however, did not affect Ca(2+) influx measured by Mn(2+) quenching. The PLC cascade and intracellular Ca(2+) release were involved as U73122 and thapsigargin inhibited RB-induced Ca(2+) oscillations. RB enhanced a Ca(2+) response to histamine that is linked to the PLC cascade. RB may activate the PLC cascade in an extracellular Ca(2+)-dependent manner and induce Ca(2+) oscillations.


Subject(s)
Calcium Channels/physiology , Calcium Signaling/physiology , Enzyme Inhibitors/pharmacology , Triazines/pharmacology , Cell Culture Techniques , HeLa Cells , Humans
20.
Am J Physiol Gastrointest Liver Physiol ; 281(3): G735-42, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11518686

ABSTRACT

Although hypergastrinemia is frequently observed in individuals with a chronic Helicobacter pylori infection, its pathophysiological significance in gastric mucosal inflammation is unclear. The present study was designed to determine if gastrin induces the expression of CXC chemokines in gastric epithelial cells. Human and rat gastric epithelial cells, transfected with gastrin receptor, were stimulated with gastrin. The expression of mRNAs for human interleukin-8 (IL-8) and rat cytokine-induced neutrophil chemoattractant-1 and release of human IL-8 protein were then determined by Northern blot analysis and ELISA, respectively. Gastrin not only induced the expression of mRNAs for these chemokines but also stimulated IL-8 protein release. A luciferase assay using IL-8 promoter genes showed that nuclear factor (NF)-kappaB is absolutely required and activator protein-1 (AP-1) is partly required for the maximum induction of IL-8 by gastrin. An electrophoretic mobility shift assay revealed that gastrin is capable of activating both NF-kappaB and AP-1. In addition, the inhibition of NF-kappaB abrogated gastrin-induced chemokine expression. These results suggest that gastrin is capable of upregulating CXC chemokines in gastric epithelial cells and therefore may contribute to the progression of the inflammatory process in the stomach.


Subject(s)
Chemokines, CXC/biosynthesis , Epithelial Cells/metabolism , Gastric Mucosa/metabolism , Gastrins/pharmacology , Intercellular Signaling Peptides and Proteins , NF-kappa B/metabolism , Animals , Cell Line , Chemokine CXCL1 , Chemokines, CXC/genetics , Chemotactic Factors/biosynthesis , Chemotactic Factors/genetics , Dose-Response Relationship, Drug , Epithelial Cells/cytology , Epithelial Cells/drug effects , Gastric Mucosa/cytology , Gastric Mucosa/drug effects , Gene Expression/drug effects , Gene Expression Regulation/drug effects , Growth Substances/biosynthesis , Growth Substances/genetics , Humans , Interleukin-1/pharmacology , Interleukin-8/biosynthesis , Interleukin-8/genetics , NF-kappa B/antagonists & inhibitors , Promoter Regions, Genetic/genetics , Pyrrolidines/pharmacology , RNA, Messenger/metabolism , Rats , Receptors, Cholecystokinin/genetics , Receptors, Cholecystokinin/metabolism , Thiocarbamates/pharmacology , Transcription Factor AP-1/metabolism , Transfection , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...